OTCMKTS:BAYRY Bayer Aktiengesellschaft 11/12/2024 Earnings Report $14.12 +0.04 (+0.28%) As of 09/24/2026 03:59 PM Eastern ProfileEarnings HistoryForecast Bayer Aktiengesellschaft EPS ResultsActual EPS$0.07Consensus EPS $0.17Beat/MissMissed by -$0.10One Year Ago EPSN/ABayer Aktiengesellschaft Revenue ResultsActual Revenue$10.96 billionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ABayer Aktiengesellschaft Announcement DetailsQuarterDate11/12/2024TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AUpcoming EarningsBayer Aktiengesellschaft's next earnings date is estimated for Tuesday, November 3, 2026, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Bayer Aktiengesellschaft Earnings HeadlinesBayer’s Real-World Kidney Study Nears Data Reveal: What Investors Should WatchSeptember 24 at 12:31 PM | tipranks.comBayer’s Hemophilia A Gene Therapy Trial Reaches Completion, Signaling Next Steps for BAYRYSeptember 23 at 12:30 PM | tipranks.comThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.September 25 at 1:00 AM | Chaikin Analytics (Ad)Grünenthal GmbH agreed to acquire Stivarga from Bayer Aktiengesellschaft.September 21, 2026 | marketscreener.comMBayer Sells Cancer Drug to Gruenenthal for Up to $431 MillionSeptember 21, 2026 | wsj.comBayer Aktiengesellschaft (OTCMKTS:BAYRY) Stock Crosses Below 50 Day Moving Average - Time to Sell?September 19, 2026 | americanbankingnews.comSee More Bayer Aktiengesellschaft Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Bayer Aktiengesellschaft? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bayer Aktiengesellschaft and other key companies, straight to your email. Email Address About Bayer AktiengesellschaftBayer Aktiengesellschaft (OTCMKTS:BAYRY) is a Germany-based life sciences company headquartered in Leverkusen. Founded in 1863, the company develops and markets products in healthcare and agriculture and serves customers in markets around the world. Bayer’s American depositary shares trade over the counter under the symbol BAYRY. The company operates through three principal areas: Pharmaceuticals, Consumer Health and Crop Science. Its Pharmaceuticals business develops prescription medicines in areas such as cardiovascular disease, women’s health, oncology, neurology and specialty therapeutics. Consumer Health offers nonprescription products, including brands in pain relief, allergy care, dermatology, nutritional supplements and digestive health. Crop Science supplies seeds, crop-protection products and digital tools designed to support farmers and improve agricultural productivity. Bayer has expanded its operations internationally through internal research and development, partnerships and acquisitions, including the acquisition of Monsanto in 2018, which strengthened its seeds and agricultural technology business. Bill Anderson has served as Bayer’s chief executive officer since June 2023 and also leads the company’s ongoing organizational transformation.View Bayer Aktiengesellschaft ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks3 Restaurant Stocks Near 52-Week Lows as Consumer Pressure BuildsPaychex Plunges, Providing the Entry Investors Have Been Waiting ForThe Case for Buying High-Yield General Mills Just StrengthenedDave’s Success Has Investors SplitEnergy Transfer Taps the AI Power BoomFull Throttle: Kratos and GE Fire Up a Next-Gen Defense Engine Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
